sorafenib has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dang, H; Hou, P; Liu, R; Liu, Y; Ma, J; Shi, B; Sui, F; Yuan, M | 1 |
| Grabowski, T; Grześkowiak, E; Karbownik, A; Sobańska, K; Stachowiak, A; Stanisławiak-Rudowicz, J; Szałek, E; Szczecińska, A; Urjasz, H; Wolc, A | 1 |
| Abbate, I; Apicella, I; Bucolo, C; D'Agata, V; De Falco, S; Giuliano, F; La Rosa, LR; Maugeri, G; Mazzone, MG; Platania, CBM; Santonocito, M; Solfato, E; Tarallo, V; Viola, S; Zappulla, C | 1 |
3 other study(ies) available for sorafenib and Alloxan Diabetes
| Article | Year |
|---|---|
Sorafenib decreases glycemia by impairing hepatic glucose metabolism.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Hypoglycemic Agents; Insulin; Insulins; Liver; Mice; Proto-Oncogene Proteins c-myc; Signal Transduction; Sorafenib | 2022 |
The oxidation and hypoglycaemic effect of sorafenib in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Animals; Area Under Curve; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Oxidation-Reduction; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sorafenib; Streptozocin | 2020 |
Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
Topics: Administration, Ophthalmic; Animals; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Emulsions; Female; Male; Mice; Mice, Inbred C57BL; Nanostructures; Protein Kinase Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Neovascularization; Sorafenib | 2021 |